Clinical recommendations regarding mild traumatic brain injury (mTBI) released

The Centers for Disease Control and Prevention (CDC) has released fresh clinical recommendations for health care personnel for treatment of children suffering from concussion or mild traumatic brain injury (mTBI). The recommendations titled “CDC Guideline on the Diagnosis and Management of Mild Traumatic Brain Injury Among Children,” was released today in the latest issue of…

Scientists trick the brain to embody the prosthetic limb

The famous idiom “seeing is believing” is not enough to help amputees with the use of their prosthetic limb. Many amputees opt out of prolonged use of their prosthetic limb because their missing limb simply does not fit their prosthesis. In other words, their own perception of the missing limb, or the brain’s representation of…

Mushrooms from the Far East area could be used to design novel anti-cancer drugs

Mushrooms from the Far East area contain the natural chemical compounds, which could be used for the design of the novel drugs with highly specific anti-tumor activities and low-toxicity. These compounds may offer new avenues for oncology, providing us with either stand-alone alternatives to chemotherapy, chemo preventive medicines, or drugs to be used in combination…

Researchers identify new regulator in breast cancer cells

Triple-negative breast cancer is a particularly aggressive form of breast cancer. Here, important receptors are missing, which often serve as targets for treatments. Thus, these tumors are unlikely to respond to current therapies. Researchers from the Leibniz Institute on Aging – Fritz Lipmann Institute (FLI) in Jena now identified the protein TRPS1, which is commonly…

Cancer Biomarkers in Clinical Use

What are Cancer Biomarkers One of the best ways to diagnose cancer early, aid in its prognosis, or predict therapeutic response, is to use serum or tissue biomarkers. Cancer biomarkers can be DNA, mRNA, proteins, metabolites, or processes such as apoptosis, angiogenesis or proliferation. The markers are produced either by the tumor itself or by…

Discovery sheds new light on pathology of Alzheimer’s disease

An association between inflammation biomarkers in both blood plasma and cerebrospinal fluid (CSF) and markers of Alzheimer’s disease (AD) associated pathology, has been found by researchers at the University of Colorado Anschutz Medical Campus working with the University of Wisconsin Alzheimer’s Disease Research Center and the University of California San Francisco Memory and Aging Center….